Taylor Beth

Chief Financial Officer at NOTV; VP Finance & Chief Acctg Offcr at ENDOCYTE INC

Sold, on record
$300k
Dollars the filings state
Form 4 sales
6
Latest Feb 17, 2026
Form 144 notices
0
Proposed sales
Quarters with a sale
2 of the last 8
3 days with a sale in that time
Companies
2
Filed as an executive or holder

Companies

  • NOTVInotiv, Inc.Chief Financial Officer
  • ENDOCYTE INCVP Finance & Chief Acctg Offcr

Sales by reason

1
Routine
3
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Feb 17, 2026Routine

    NOTV

    Sold 1.9% of their holdings

    $8382,888 shares at $0.29

    Filed Feb 19, 2026Form 4

  2. Feb 18, 2025No plan

    NOTV

    Sold 3.9% of their holdings

    $18k4,370 shares at $4.01

    Filed Feb 20, 2025Form 4

  3. Jan 31, 2025No plan

    NOTV

    Sold 1.8% of their holdings

    $9k2,054 shares at $4.47

    Filed Feb 4, 2025Form 4

  4. Oct 5, 2018Plan not stated

    ENDOCYTE INC

    Sold 11.1% of their holdings

    $109k7,022 shares at $15.56

    Filed Oct 9, 2018Form 4

  5. Aug 28, 2018Plan not stated

    ENDOCYTE INC

    Sold 11.1% of their holdings

    $158k7,892 shares at $20.00

    Filed Aug 29, 2018Form 4

  6. Aug 20, 2018Plan not stated

    ENDOCYTE INC

    Sold 0.4% of their holdings

    $5k285 shares at $18.20

    Filed Aug 22, 2018Form 4

6 of 6

Every transaction

Every transaction on a Form 4 or Form 5 by Taylor Beth
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Jul 19, 2026Jul 20, 2026NOTVChief Financial OfficerOther139,6160SEC
Jun 18, 2026Jun 23, 2026NOTVChief Financial OfficerWithheld for tax5,864$0.0200$117139,616SEC
Feb 17, 2026Feb 19, 2026NOTVChief Financial OfficerSold2,888$0.29$838145,480SEC
Mar 14, 2025Mar 18, 2025NOTVChief Financial OfficerAwarded40,000148,368SEC
Feb 21, 2025Feb 25, 2025NOTVChief Financial OfficerAwardedEmployee Stock Option (right to buy)6,5006,500SEC
Feb 18, 2025Feb 20, 2025NOTVChief Financial OfficerSold4,370$4.01$18k108,368SEC
Jan 31, 2025Feb 4, 2025NOTVChief Financial OfficerSold2,054$4.47$9k112,738SEC
Aug 10, 2024Aug 14, 2024NOTVChief Financial OfficerAwardedEmployee Stock Option (right to buy)20,00020,000SEC
Aug 10, 2024Aug 14, 2024NOTVChief Financial OfficerAwarded20,000114,792SEC
Dec 15, 2023Dec 15, 2023NOTVChief Financial OfficerAwardedEmployee Stock Option (right to buy)6,2506,250SEC
Feb 17, 2023Feb 21, 2023NOTVChief Financial OfficerAwarded5,00094,792SEC
Jan 18, 2023Jan 20, 2023NOTVChief Financial OfficerAwarded5,91789,792SEC
Feb 18, 2022Feb 22, 2022NOTVVP- Finance & CFOBought5,000$23.07$115k83,875SEC
Feb 15, 2022Feb 17, 2022NOTVVP- Finance & CFOAwarded40,00078,875SEC
Dec 17, 2021Dec 20, 2021NOTVVP- Finance & CFOAwarded21438,875SEC
Oct 22, 2021Oct 26, 2021NOTVVP- Finance & CFOAwarded1,33238,661SEC
May 13, 2021May 17, 2021NOTVVP- Finance & CFOBought2,154$23.14$50k37,329SEC
May 7, 2021May 11, 2021NOTVVP- Finance & CFOAwarded88035,175SEC
Mar 5, 2021Mar 5, 2021NOTVVP- Finance & CFOBought5,000$17.70$89k34,295SEC
Dec 2, 2020Dec 4, 2020NOTVVP- Finance & CFOAwarded5,99529,295SEC
Jun 10, 2020Jun 11, 2020NOTVVP- Finance & CFOAwarded10,00023,300SEC
May 21, 2020May 21, 2020NOTVVP- Finance & CFOBought13,300$4.43$59k13,300SEC
Dec 21, 2018Dec 21, 2018ENDOCYTE INCVP Finance & Chief Acctg OffReturned to the companyStock Option (right to buy)100,261$18.55$1.9M0SEC
Dec 21, 2018Dec 21, 2018ENDOCYTE INCVP Finance & Chief Acctg OffReturned to the company99,509$24.00$2.4M0SEC
Dec 19, 2018Dec 19, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrGift8,1861,250SEC
Dec 17, 2018Dec 19, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrExercised or settledStock option (right to buy)48,85415,000SEC
Dec 17, 2018Dec 19, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrExercised options48,854$4.31$211k105,195SEC
Oct 5, 2018Oct 9, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrSold7,022$15.56$109k56,341SEC
Aug 28, 2018Aug 29, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrSold7,892$20.00$158k63,363SEC
Aug 20, 2018Aug 22, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrSold285$18.20$5k71,255SEC
Feb 8, 2018Feb 8, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrAwardedStock Option (right to buy)25,00025,000SEC
Feb 8, 2018Feb 8, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrAwarded12,50071,540SEC
Feb 6, 2018Feb 8, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrWithheld for tax484$3.00$1k59,040SEC
Feb 4, 2018Feb 6, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrWithheld for tax1,759$3.12$5k59,524SEC
Oct 4, 2017Oct 6, 2017ENDOCYTE INCVP Finance & Chief Acctg OffcrAwarded30,00061,283SEC
Feb 2, 2017Feb 3, 2017ENDOCYTE INCVP Finance & Chief Acctg OffcrAwardedStock Option (right to buy)20,00020,000SEC
Feb 2, 2017Feb 3, 2017ENDOCYTE INCVP Finance & Chief Acctg OffcrAwarded10,00031,283SEC
Aug 18, 2016Aug 22, 2016ENDOCYTE INCVP Finance & Chief Acctg OffcrAwardedStock Option (right to buy)22,50022,500SEC
Aug 18, 2016Aug 22, 2016ENDOCYTE INCVP Finance & Chief Acctg OffcrAwarded3,75021,283SEC
Feb 6, 2016Feb 8, 2016ENDOCYTE INCCorporate ControllerWithheld for tax525$3.02$2k16,482SEC
Feb 4, 2016Feb 8, 2016ENDOCYTE INCCorporate ControllerAwardedStock Option (right to buy)7,5007,500SEC
Feb 4, 2016Feb 8, 2016ENDOCYTE INCCorporate ControllerAwarded3,75017,007SEC
Feb 6, 2015Feb 6, 2015ENDOCYTE INCCorporate ControllerWithheld for tax525$5.14$3k11,627SEC
Feb 4, 2015Feb 6, 2015ENDOCYTE INCCorporate ControllerAwardedStock Option (right to buy)9,0009,000SEC
Feb 4, 2015Feb 6, 2015ENDOCYTE INCCorporate ControllerAwarded4,50012,152SEC
Feb 6, 2014Feb 10, 2014ENDOCYTE INCCorporate ControllerAwardedStock Option (right to buy)10,85010,850SEC
Feb 6, 2014Feb 10, 2014ENDOCYTE INCCorporate ControllerAwarded5,4257,147SEC
Feb 19, 2013Feb 21, 2013ENDOCYTE INCCorporate ControllerAwardedStock Option (right to buy)14,36214,362SEC
Feb 29, 2012Mar 2, 2012ENDOCYTE INCCorporate ControllerAwardedStock Option (right to buy)16,07316,073SEC

Sales and notices (6)

Form 144 notices and Form 4 sales by Taylor Beth
Source
Feb 17, 2026Feb 19, 2026NOTVChief Financial OfficerForm 4 sale2,888$8381.9%RoutineSEC
Feb 18, 2025Feb 20, 2025NOTVChief Financial OfficerForm 4 sale4,370$18k3.9%No planSEC
Jan 31, 2025Feb 4, 2025NOTVChief Financial OfficerForm 4 sale2,054$9k1.8%No planSEC
Oct 5, 2018Oct 9, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrForm 4 sale7,022$109k11.1%Plan not statedSEC
Aug 28, 2018Aug 29, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrForm 4 sale7,892$158k11.1%Plan not statedSEC
Aug 20, 2018Aug 22, 2018ENDOCYTE INCVP Finance & Chief Acctg OffcrForm 4 sale285$5k0.4%Plan not statedSEC